Oral semaglutide in type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of diabetes and its complications"
DOI: 10.1016/j.jdiacomp.2019.107520
Abstract: BACKGROUND Previously, the only available glucagon-like peptide-1 receptor agonists (GLP-1 RA) were injectable. Approval of oral semaglutide (Rybelsus®) represents the first orally available GLP-1 RA. OBJECTIVE To review the literature and describe pharmacologic, pharmacokinetic, and… read more here.
Keywords: type diabetes; semaglutide type; oral semaglutide; semaglutide ... See more keywords